BACKGROUND: Zika-exposed infants with microcephaly (proportional or disproportional) and those who are small for gestational age without microcephaly should be closely followed, particularly their growth trajectories. They are at high risk of adverse outcomes in the first year of life.Antenatal Zika virus (ZIKV) exposure may lead to adverse infant outcomes including microcephaly and being small for gestational age (SGA). ZIKV-exposed infants with a diagnosis of microcephaly (proportional [PM] or disproportional [DM]) or SGA at birth were evaluated with anthropometric measurements and health outcomes. METHODS: Infants had laboratory-confirmed ZIKV exposure in Brazil. PM, DM, or SGA classification was based on head circumference and weight. First-year growth parameters and clinical outcomes were recorded with analyses performed. RESULTS: Among the 156 ZIKV-exposed infants, 14 (9.0%) were SGA, 13 (8.3%) PM, 13 (8.3%) DM, and 116 (74.4%) were neither SGA nor had microcephaly (NSNM). High rates of any neurologic, ophthalmologic, and hearing abnormalities were observed for PM (100%), DM (100%), and SGA (42.9%) vs NSNM infants (18.3%; P <.001); odds ratio [OR], 3.4 (95% confidence interval [CI], 1.1-10.7) for SGA vs NSNM. Neuroimaging abnormalities were seen in 100% of PM and DM and in 42.9% of SGA vs NSNM infants 16%; (P <.001); OR 3.9 (95% CI, 1.2-12.8) for SGA vs NSNM. Growth rates by z score, particularly for microcephaly infants, were poor after birth but showed improvement beyond 4 months of life. CONCLUSIONS: ZIKV-exposed infants with microcephaly (PM and DM) had similarly high rates of adverse outcomes but showed improvement in growth measurements beyond 4 months of life. While SGA infants had fewer adverse outcomes compared with microcephaly infants, notable adverse outcomes were observed in some; their odds of having adverse outcomes were 3 to 4 times greater compared to NSNM infants.Zika-exposed infants with microcephaly, irrespective of being proportional or disproportional, and those who are small for gestational age without microcephaly should be closely followed, particularly their growth trajectories. They are at high risk of adverse outcomes in the first year of life.
BACKGROUND: Zika-exposed infants with microcephaly (proportional or disproportional) and those who are small for gestational age without microcephaly should be closely followed, particularly their growth trajectories. They are at high risk of adverse outcomes in the first year of life.Antenatal Zika virus (ZIKV) exposure may lead to adverse infant outcomes including microcephaly and being small for gestational age (SGA). ZIKV-exposed infants with a diagnosis of microcephaly (proportional [PM] or disproportional [DM]) or SGA at birth were evaluated with anthropometric measurements and health outcomes. METHODS: Infants had laboratory-confirmed ZIKV exposure in Brazil. PM, DM, or SGA classification was based on head circumference and weight. First-year growth parameters and clinical outcomes were recorded with analyses performed. RESULTS: Among the 156 ZIKV-exposed infants, 14 (9.0%) were SGA, 13 (8.3%) PM, 13 (8.3%) DM, and 116 (74.4%) were neither SGA nor had microcephaly (NSNM). High rates of any neurologic, ophthalmologic, and hearing abnormalities were observed for PM (100%), DM (100%), and SGA (42.9%) vs NSNM infants (18.3%; P <.001); odds ratio [OR], 3.4 (95% confidence interval [CI], 1.1-10.7) for SGA vs NSNM. Neuroimaging abnormalities were seen in 100% of PM and DM and in 42.9% of SGA vs NSNM infants 16%; (P <.001); OR 3.9 (95% CI, 1.2-12.8) for SGA vs NSNM. Growth rates by z score, particularly for microcephaly infants, were poor after birth but showed improvement beyond 4 months of life. CONCLUSIONS: ZIKV-exposed infants with microcephaly (PM and DM) had similarly high rates of adverse outcomes but showed improvement in growth measurements beyond 4 months of life. While SGA infants had fewer adverse outcomes compared with microcephaly infants, notable adverse outcomes were observed in some; their odds of having adverse outcomes were 3 to 4 times greater compared to NSNM infants.Zika-exposed infants with microcephaly, irrespective of being proportional or disproportional, and those who are small for gestational age without microcephaly should be closely followed, particularly their growth trajectories. They are at high risk of adverse outcomes in the first year of life.
Authors: Liana O Ventura; Camila V Ventura; Natália de C Dias; Isabelle G Vilar; Adriana L Gois; Tiago E Arantes; Luciene C Fernandes; Michael F Chiang; Marilyn T Miller; Linda Lawrence Journal: J AAPOS Date: 2018-04-12 Impact factor: 1.220
Authors: Cynthia A Moore; J Erin Staples; William B Dobyns; André Pessoa; Camila V Ventura; Eduardo Borges da Fonseca; Erlane Marques Ribeiro; Liana O Ventura; Norberto Nogueira Neto; J Fernando Arena; Sonja A Rasmussen Journal: JAMA Pediatr Date: 2017-03-01 Impact factor: 16.193
Authors: J R Corona-Rivera; E Corona-Rivera; E Romero-Velarde; J Hernández-Rocha; L Bobadilla-Morales; A Corona-Rivera Journal: Eur J Pediatr Date: 2001-11 Impact factor: 3.183
Authors: Bruno de Paula Freitas; João Rafael de Oliveira Dias; Juliana Prazeres; Gielson Almeida Sacramento; Albert Icksang Ko; Maurício Maia; Rubens Belfort Journal: JAMA Ophthalmol Date: 2016-05-01 Impact factor: 7.389
Authors: Antonio Augusto Moura da Silva; Jucelia Sousa Santos Ganz; Patricia da Silva Sousa; Maria Juliana Rodvalho Doriqui; Marizelia Rodrigues Costa Ribeiro; Maria Dos Remédios Freitas Carvalho Branco; Rejane Christine de Sousa Queiroz; Maria de Jesus Torres Pacheco; Flavia Regina Vieira da Costa; Francelena de Sousa Silva; Vanda Maria Ferreira Simões; Marcos Antonio Barbosa Pacheco; Fernando Lamy-Filho; Zeni Carvalho Lamy; Maria Teresa Seabra Soares de Britto E Alves Journal: Emerg Infect Dis Date: 2016-11 Impact factor: 6.883
Authors: Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Jason O Velez; Amy J Lambert; Alison J Johnson; Stephanie M Stanfield; Mark R Duffy Journal: Emerg Infect Dis Date: 2008-08 Impact factor: 6.883
Authors: Jessica S Cranston; Sophia Finn Tiene; Karin Nielsen-Saines; Zilton Vasconcelos; Marcos V Pone; Sheila Pone; Andrea Zin; Tania Saad Salles; Jose Paulo Pereira; Dulce Orofino; Patricia Brasil; Tara Kerin; Kristina Adachi; Fernanda Mendes Soares; Andrea Dunshee de Abranches; Ana Carolina C da Costa; Maria Elisabeth Lopes Moreira Journal: JAMA Netw Open Date: 2020-07-01
Authors: Maria Conceição N Costa; Luciana Lobato Cardim; Maria Gloria Teixeira; Mauricio L Barreto; Rita de Cassia Oliveira de Carvalho-Sauer; Florisneide R Barreto; Martha Suely Itaparica Carvalho; Wanderson K Oliveira; Giovanny V A França; Eduardo Hage Carmo; Roberto F S Andrade; Moreno S Rodrigues; Rafael V Veiga; Juliane F Oliveira; Qeren H R F Fernandes; Larissa C Costa; Giovanini E Coelho; Enny S Paixao Journal: Viruses Date: 2020-10-29 Impact factor: 5.048
Authors: Annelies Wilder-Smith; Elizabeth B Brickley; Ricardo Arraes de Alencar Ximenes; Demócrito de Barros Miranda-Filho; Celina Maria Turchi Martelli; Tom Solomon; Bart C Jacobs; Carlos A Pardo; Lyda Osorio; Beatriz Parra; Suzannah Lant; Hugh J Willison; Sonja Leonhard; Lance Turtle; Maria Lúcia Brito Ferreira; Rafael Freitas de Oliveira Franca; Louis Lambrechts; Johan Neyts; Suzanne Kaptein; Rosanna Peeling; Deborah Boeras; James Logan; Helen Dolk; Ieda M Orioli; Andreas Neumayr; Trudie Lang; Bonny Baker; Eduardo Massad; Raman Preet Journal: Glob Health Action Date: 2021-10-26 Impact factor: 2.640